Contrast Enhancement on Coronary Computed Tomographic Angiography
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT02462044
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT02462044
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT02462044. Randomized; double masking; primary purpose diagnostic. Start 2014-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Contrast Enhancement on Coronary Computed Tomographic Angiography
- Acronym
- EICAR
- Condition
- Coronary Artery Disease
- Condition
- Coronary Stenosis
- Intervention (Drug)
- 240 mg Iodine
- Intervention (Drug)
- 300 mg Iodine
- Intervention (Drug)
- 370 mg Iodine
- Lead sponsor
- Maastricht University Medical Center
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct02462044- Content hash
caa36970291e3f896678ec6ec58430f15af52173613b949831dfbf6635e66a42